Overview
Shuta Tomida practices in Okayama, Japan. Tomida is rated as an Advanced expert by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). Their top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, Stomach Cancer, and Lung Transplant.
Their clinical research consists of co-authoring 136 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 35 articles in the study of Non-Small Cell Lung Cancer (NSCLC).
Locations
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Lung CancerTomida isDistinguished. Learn about Lung Cancer.
- Advanced
- EGFR Positive Lung CancerTomida isAdvanced. Learn about EGFR Positive Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)
- Experienced
- Acute Interstitial PneumoniaTomida isExperienced. Learn about Acute Interstitial Pneumonia.
- Adult Soft Tissue SarcomaTomida isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Breast CancerTomida isExperienced. Learn about Breast Cancer.
- Castleman DiseaseTomida isExperienced. Learn about Castleman Disease.
- Colorectal CancerTomida isExperienced. Learn about Colorectal Cancer.
- GastritisTomida isExperienced. Learn about Gastritis.